US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist

1.290
+0.080+6.61%

Close Nov 21 16:00 ET

1.290
0.0000.00%

Post 16:20 ET

68.04MMarket Cap-434P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALX Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

ALX Oncology Earnings Reports

ALX Oncology | 10-Q: Q3 2024 Earnings Report

Nov 7 16:09 ET

ALX Oncology | 10-Q: Q2 2024 Earnings Report

Aug 12 16:08 ET

ALX Oncology | 10-Q: Q1 2024 Earnings Report

May 9 17:08 ET

ALX Oncology | 10-K: FY2023 Annual Report

Mar 7 22:16 ET

Analyst Rating

Updated: Nov 21, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall